![]() |
市場調查報告書
商品編碼
1295309
醫用塗料市場 - 2023-2028 年預測Medical Coating Market - Forecasts from 2023 to 2028 |
醫療設備、植入物和小工具需要塗上材料和塗層,以提高功能和安全性。 傳染病的流行、微創手術技術的擴展以及對醫療設備的強勁需求推動了市場增長。 此外,對定制多功能塗料不斷增長的需求預計將顯著擴大市場。 此外,持續的研究和開發提供了新的、獨特的塗層選擇。 此外,市場進入者的產品創新和戰略行動正在為擴展到新的應用領域創造大量機會。
然而,預計限制該市場增長的因素是原材料價格上漲和塗層失效風險。 使用具有親水/疏水塗層的醫療器械存在塗層缺陷的風險,這是市場增長的主要挑戰之一。 此外,其他重要因素,例如塗層類型導致的生物相容性有限、缺乏標準化方法、塗層失效的可能性以及塗層的耐久性,也阻礙了市場的增長。
感染率增加與住院時間延長有關。 常見的醫院感染是由導尿管、中心靜脈導管和機械呼吸機等醫療器械引起的。 由於醫療器械與人體接觸,因此成為醫院獲得性感染傳播的媒介。 因此,出於減少醫院感染的需要,醫療器械上的抗菌塗層越來越受歡迎。 這似乎是在不影響患者護理的情況下加強醫院環境感染控制的最有效方法。 隨著醫院獲得性感染的增加,抗菌塗層的使用正在擴大。 例如,根據美國疾病控制與預防中心的數據,醫療保健相關感染每年導致超過 98,000 人死亡,並感染約 170 萬住院患者。 另外,根據重症監護感染率擴展調查,ICU內感染患者的比例高達51%。
此外,慢性病的流行正在推動各種醫療程序的使用。 這增加了對醫用塗層解決方案的需求,增加了醫療保健支出,並對市場的擴張產生了重大影響。 例如,根據美國醫療保健協會的數據,2021年美國醫療保健支出將達到4.3萬億美元,增長2.7%,達到人均12,914美元。 這正在推動醫用塗料市場的發展。 此外,美國國內生產總值的 18.3% 用於醫療保健。
醫療設備需要特定的性能特徵,例如減少摩擦、提高耐磨性、增強生物相容性和提高耐用性。 噴塗可以根據這些要求進行定制,提供一種經濟有效的方法來提高醫療器械的性能和功能,從而推動醫療塗料市場對噴塗的需求。
按地區劃分,醫用塗料市場分為北美、南美、歐洲、中東和非洲以及亞太地區。
印度醫用塗料市場預計在預測期內將大幅增長。 這種增長是由於印度人口老齡化等多種因素造成的。 隨著人口老齡化,對醫療設備和裝置的需求也在增加,從而增加了對醫用塗料的需求。 醫用塗料在確保醫療器械的安全性和有效性方面發揮著重要作用。 提供保護層,防止污染、提高耐用性並提高生物相容性。 這對於印度的老齡化社會尤其重要,因為印度容易發生感染,需要長期住院。 例如,2021年,帝斯曼生物醫學在印度推出了新型親水塗層2.0,旨在提高血管介入治療中使用的醫療器械的性能和安全性。
此外,癌症、糖尿病和心血管疾病等慢性疾病的流行正在推動印度醫用塗料市場的增長。 這些疾病通常需要支架、導管和植入物等醫療設備,而這些設備在很大程度上依賴於醫用塗層才能正常發揮作用。 印度慢性病患病率上升是由生活方式改變、城市化進程加快和人口老齡化等多種因素造成的。 全球疾病負擔還估計,印度的糖尿病患病率將從1990年的26□□00萬增加到2019年的7700萬,並在2030年進一步增加到1.01億。預測。 此外,2018年印度新增癌症患者116萬,預計2040年將增至162萬。
Medical equipment, implants, and gadgets must be coated with materials or coatings to enhance their functionality and safety. The prevalence of infections, the expansion of minimally invasive surgical techniques, and the strong demand for medical devices are all contributing reasons to the market's growth. Additionally, this market is anticipated to expand significantly due to the rising demand for customized and multifunctional coatings. Further, ongoing research and development offer new, creative coating options. In addition, product innovation and strategic actions by major market participants create numerous opportunities to expand into new application areas.
However, the factors that are anticipated to restrain the growth of this market are the rising prices of raw materials and the risk of coating failures. The use of hydrophilic and hydrophobic coated medical equipment carries a risk of coating failure, which is one of the main challenges for the growth of this market. In addition, other significant factors like the biocompatibility restrictions on some coating types, the lack of standardized practices, the possibility of coating failure, and the durability of the coating will also hamper the market growth.
The increasing rates of infections are associated with longer hospital stays. Common hospital-acquired infections are caused by medical equipment such as urine catheters, central lines, and mechanical ventilators. As they come into contact with the human body, they serve as a vehicle for the spread of hospital-acquired illnesses. Therefore, antimicrobial coatings on medical devices are becoming more popular due to the need to lower hospital-acquired infections. This is because it seems to be the most effective way to enhance infection control in a hospital environment without sacrificing patient care. With the rise in hospital-acquired infections, the usage of antimicrobial coatings is expanding. For instance, according to the U.S. Center for Disease Control and Prevention, more than 98,000 individuals die due to healthcare-associated infections, which affect about 1.7 million hospitalized patients every year. In addition, the percentage of infected patients within the ICU is as high as 51%, according to the Extended Prevalence of Infection in Intensive Care research.
Moreover, the prevalence of chronic diseases is driving the use of various medical procedures. This, in turn, is augmenting the demand for medical coating solutions and increasing healthcare expenditure, significantly influencing the market's expansion. For instance, as per the American Healthcare Association, healthcare spending in the U.S. rose by 2.7 percent in 2021 to reach USD 4.3 trillion, accounting for USD 12,914 per person. This aids in boosting the medical coating market. Additionally, 18.3% of the United States Gross Domestic Product was spent on health care.
Medical devices require specific performance characteristics, such as reduced friction, improved wear resistance, enhanced biocompatibility, and increased durability. Spray coatings can be tailored to meet these requirements, providing a cost-effective and efficient way to improve the performance and functionality of medical devices, which drives the demand for spray coatings in the medical coating market.
The medical coating market has been segmented by geography into North America, South America, Europe, Middle East and Africa, and Asia Pacific.
The Indian medical coating market is expected to grow significantly during the projected period. This growth can be attributed to various factors, such as the aging population in India. As the population ages, the demand for medical devices and equipment also increases, which drives the need for medical coatings. Medical coatings play a crucial role in ensuring the safety and effectiveness of medical devices. They provide a protective layer that prevents contamination, improves durability, and enhances biocompatibility. This is particularly important for the aging population in India, who are more susceptible to infections and require longer hospital stays. For instance, in 2021, DSM Biomedical launched its new Hydrophilic Coating 2.0 in India, designed to improve the performance and safety of medical devices used in vascular interventions.
Moreover, the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases in India is driving the growth of the medical coating market. These conditions often require medical devices such as stents, catheters, and implants, which rely heavily on medical coatings to function properly. The rising prevalence of chronic diseases in India can be attributed to several factors, including changes in lifestyle, increased urbanization, and an aging population. In addition, the Global Burden of Disease estimates that the prevalence of diabetes in India has risen from 26 million in 1990 to 77 million in 2019, with projections indicating a further increase to 101 million by 2030. The study also estimates that there were 1.16 million new cancer cases in India in 2018, which is projected to increase to 1.62 million cases by 2040.